| 9th Nov 2023 7:00 am |
RNS |
Initiation of food effects study for SDC-1801 |
| 8th Nov 2023 3:03 pm |
RNS |
Director Dealings |
| 3rd Nov 2023 7:05 am |
RNS |
Sareum enhances SDC-1801 patent protection |
| 2nd Nov 2023 2:48 pm |
RNS |
Exercise of Share Options and Director Dealings |
| 9th Oct 2023 7:00 am |
RNS |
Final Results for the Year Ended 30 June 2023 |
| 3rd Oct 2023 7:00 am |
RNS |
Notice of Results and Investor Presentation |
| 6th Sep 2023 7:00 am |
RNS |
Director's Dealing |
| 5th Sep 2023 7:00 am |
RNS |
Director Dealing |
| 4th Sep 2023 7:00 am |
RNS |
Dosing of first subjects in MAD Phase 1a trial |
| 16th Aug 2023 7:00 am |
RNS |
Update on financial and operational progress |
| 3rd Aug 2023 7:00 am |
RNS |
Equity Prepayment Facility of up to £5 million |
| 26th Jun 2023 7:00 am |
RNS |
Sareum Announces Two New Granted Patents |
| 6th Jun 2023 7:00 am |
RNS |
Dosing commences in Phase 1a trial of SDC-801 |
| 18th May 2023 7:00 am |
RNS |
Phase 1a clinical trial for SDC-1801 |
| 5th May 2023 9:20 am |
RNS |
Approval to initiate Phase 1 clinical trial |
| 22nd Mar 2023 7:00 am |
RNS |
Half-Year Report |
| 15th Mar 2023 7:01 am |
RNS |
Update on SDC-1801 |
| 15th Mar 2023 7:00 am |
RNS |
Notice of Half-Year Results |
| 6th Mar 2023 7:00 am |
RNS |
Update on SRA737 |
| 29th Dec 2022 3:14 pm |
RNS |
Director/PDMR Shareholding |
| 16th Dec 2022 3:29 pm |
RNS |
Results of AGM |
| 16th Dec 2022 7:00 am |
RNS |
AGM Statement |
| 24th Nov 2022 7:00 am |
RNS |
Notice of AGM, Annual Report and Accounts |
| 21st Nov 2022 7:00 am |
RNS |
Sareum notes publication of SRA737 clinical data |
| 9th Nov 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 9th Nov 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 9th Nov 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 9th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 9th Nov 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 9th Nov 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 9th Nov 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 9th Nov 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 8th Nov 2022 5:23 pm |
RNS |
Update on SDC-1801 CTA Application |
| 24th Oct 2022 7:00 am |
RNS |
Final Results for the Year Ended 30 June 2022 |
| 12th Oct 2022 7:00 am |
RNS |
Update on SRA737 |
| 30th Sep 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 30th Sep 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 12th Sep 2022 7:00 am |
RNS |
Sareum notes FDA approval of first TYK2 Inhibitor |
| 28th Jul 2022 7:00 am |
RNS |
CTA application to MHRA and Corporate Update |
| 4th Jul 2022 7:00 am |
RNS |
Sareum notes GSK's completed acquisition of Sierra |
